HPCM
CVS icon

High Pointe Capital Management’s CVS Health CVS Stock Holding History

High Pointe Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-35,800
Closed -$2.12M – 81
2020
Q1 		$2.12M Sell
35,800
-740
-2% -$49.4K 3.03% 6
2019
Q4 		$2.71M Sell
36,540
-60
-0.2% -$4.21K 3.22% 5
2019
Q3 		$2.31M Sell
36,600
-100
-0.3% -$5.93K 3.16% 4
2019
Q2 		$2M Buy
36,700
+11,180
+44% +$602K 2.8% 7
2019
Q1 		$1.38M Sell
25,520
-260
-1% -$16K 1.88% 15
2018
Q4 		$1.69M Sell
25,780
-290
-1% -$21.6K 2.78% 4
2018
Q3 		$2.05M Hold
26,070
– – 2.76% 4
2018
Q2 		$1.68M Sell
26,070
-120
-0.5% -$7.91K 2.39% 7
2018
Q1 		$1.63M Buy
26,190
+6,820
+35% +$489K 2.24% 10
2017
Q4 		$1.4M Hold
19,370
– – 1.92% 15
2017
Q3 		$1.57M Buy
19,370
+170
+0.9% +$13.4K 2.31% 9
2017
Q2 		$1.54M Buy
19,200
+40
+0.2% +$3.16K 2.4% 7
2017
Q1 		$1.5M Hold
19,160
– – 2.38% 11
2016
Q4 		$1.51M Buy
19,160
+7,330
+62% +$593K 2.49% 9
2016
Q3 		$1.05M Sell
11,830
-5,040
-30% -$476K 1.87% 22
2016
Q2 		$1.61M Sell
16,870
-1,150
-6% -$115K 2.46% 11
2016
Q1 		$1.87M Sell
18,020
-20,990
-54% -$2.04M 2.7% 7
2015
Q4 		$3.81M Sell
39,010
-11,328
-23% -$1.11M 1.87% 5
2015
Q3 		$4.86M Buy
50,338
+548
+1% +$57.6K 2.28% 3
2015
Q2 		$5.22M Buy
49,790
+960
+2% +$98.1K 1.87% 3
2015
Q1 		$5.04M Buy
48,830
+16,260
+50% +$1.65M 1.81% 3
2014
Q4 		$3.14M Buy
32,570
+3,520
+12% +$310K 1.38% 5
2014
Q3 		$2.31M Sell
29,050
-1,400
-5% -$110K 1% 24
2014
Q2 		$2.29M Buy
+30,450
New +$2.3M 0.84% 50
2013
Q4 		– Sell
-6,300
Closed -$358K – 163
2013
Q3 		$358K Hold
6,300
– – 0.14% 120
2013
Q2 		$360K Buy
+6,300
New +$365K 0.16% 120

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

High Pointe Capital Management's CVS Position: Q2 2020 in Review

High Pointe Capital Management sold out of CVS Health (CVS) in Q2 2020, closing a stake of 35,800 shares — an estimated $2.12M sold.

High Pointe Capital Management first reported a position in CVS in Q2 2013 and held it in 26 quarters. The position peaked at $5.22M in Q2 2015. 1,863 funds tracked by Wall St. Rank hold CVS as of Q2 2020.

  • High Pointe Capital Management reported no remaining CVS Health position as of Q2 2020 after selling out during the quarter.
  • High Pointe Capital Management sold 35,800 CVS Health shares in Q2 2020, an estimated $2.12M.
  • High Pointe Capital Management first reported a position in CVS Health in Q2 2013 and held it in 26 quarters.
  • High Pointe Capital Management's CVS Health position peaked at $5.22M in Q2 2015.
  • 1,863 funds tracked by Wall St. Rank held CVS Health as of Q2 2020.

Based on High Pointe Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.